Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu met the study’s primary objective, and showed superior efficacy in the primary endpoint of time to improvement of influenza symptoms versus placebo.

When we think of summer, we usually think of outdoor fun like swimming, cookouts, sporting events and going to the park. But with summer also comes a combination of heat and smog that can create bad air quality. Heat, air pollution and ragweed pollen create problems in the fall too. Since we spend more time outside in these warmer months, these combinations can be hard on your airways.

If you’ve never suffered from eczema, also known as atopic dermatitis, you probably aren’t aware of the negative impact it can have on quality of life. The severe itching, redness and excessively dry skin all make life miserable for those who suffer from the allergic disease.

Although about 10 percent of school-aged children in the United States have asthma, there are few comprehensive U.S. guidelines for treating pediatric asthma. The Pediatric Asthma Yardstick, a new guideline from the American College of Allergy, Asthma and Immunology (ACAAI), offers a user-friendly “operational document”. It helps health care professionals understand which controller treatments are right for which age groups and identifies when a step up is needed.